A comparison of community pharmacists' views of over-the-counter omeprazole and simvastatin-Reference-Cited by-同舟云学术

A comparison of community pharmacists' views of over-the-counter omeprazole and simvastatin

Published:2007 Issue:12 Volume:16 Page:1290-1297
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidem. Drug Safe.

Author:

Stewart Derek,John Dai,Cunningham Scott,McCaig Dorothy,Hansford Denise

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Reference29 articles.

1. Reclassification summary for simvastatin POM to P. Medicines and Healthcare Products Regulatory Agency at http://medicines.mhra_gov.uk [Accessed March 2006].

2. Pharmacy in the future—implementing the NHS plan. London. Department of Health; 2000. Available at http://www.dh.gov.uk/assetRoot/04/06/82/04/04068204.pdf [Accessed 24th November 2006].

3. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantitative Methods in Pharmacy Practice Research;Encyclopedia of Pharmacy Practice and Clinical Pharmacy;2019

2. Australian pharmacy perspectives on increasing access to medicines through reclassification;Journal of Health Services Research & Policy;2018-10-23

3. Barriers to positive policy change that aims to increase access to medicines through reclassification: the case of oseltamivir in New Zealand;International Journal of Pharmacy Practice;2015-07-07

4. Expanding Consumer Medication Access: The Time Is Now;Therapeutic Innovation & Regulatory Science;2013-03

5. The influence of evidence-based medicine training on decision-making in relation to over-the-counter medicines: a qualitative study;International Journal of Pharmacy Practice;2012-06-14